Request for Covid-19 Impact Assessment of this Report
Body temperature is considered as an essential indicator of physical well-being and is measured using thermometers. Non-contact thermometers are utilized to address Ebola concerns. There is a requirement for safe, precise deep-tissue temperature detecting and more efficient options in this field.
End-user/Technology
The top users of this technology are mostly from Healthcare institutions (hospitals, medical schools, group practices, individual surgeons, and governing bodies), diagnostic centers & research institutes.
Market Dynamics
The global body temperature monitoring market is expected to grow at a CAGR of 7.1 % for the next decade. Various factors such as the increasing prevalence of acquired infections and awareness are the reasons behind the demand in sophistication of devices
Market Segmentation
The global body temperature monitoring market is segmented on the basis of the type of product- contact thermometers (digital thermometers, digital thermometers, infrared thermometers, infrared ear thermometers, IR temporal artery thermometer, electronic temperature monitors, temperature strips, body temperature monitoring pills, clinical colour change thermometer, mercury thermometer, disposable probe covers, single-use chemical dot thermometers, brain temperature monitoring system) and non-contact thermometers (noncontact infrared thermometers, thermal scanners by portability (portable, non-portable). By method (invasive, non-invasive), by users (hospitals, clinics) and by geography as North America, Europe, Asia-Pacific, Latin America and Middle East & Africa.
Regional/Geographic Analysis
Geographically, the global neurology monitoring market is classified into regions namely, North America, Latin America, Western Europe, Eastern Europe, Asia-Pacific, Japan, Middle East and Africa. As of 2015, North America (comprising the U.S. and Canada) held the most significant share of the market. Many factors such as the severity of common flu and various other diseases which can be readily detected by abnormal body temperatures present a substantial demand structure. However, the Asia-Pacific region is well on line to be a very large market to cater as expected. Rising initiatives by various private and government organizations for the use of such equipment to prevent the disease from spreading.
Opportunities
The substantial development is driven by the rising predominance of infectious diseases alongside surging interest of advanced thermometer. Apart from that, the downfall in the mercury construct thermometer is accounted concerning the increasing awareness about the disadvantages offered by the mercury thermometers has been keeping down the purchasers from utilizing mercury thermometers
Key Players
Some of the key players in the market are 3M Company, A&D Medical/LifeSource, Actherm, Inc., American Diagnostic Corporation, Braemar Manufacturing, LLC (USA), Fukuda Denshi Co., Ltd. (Japan), GE Healthcare UK Ltd. (UK), LivaNova PLC (UK), Medicomp, Inc. (USA), Mortara Instrument, Inc. (USA), Philips Healthcare (USA), Schiller AG (Switzerland), ScottCare Corporation (USA), Spacelabs Healthcare, Inc. (USA), and Briggs Healthcare.
Report Contents:
> Market segments
> Market Drivers, Restraints and Opportunities
> Market Size & Forecast 2016 to 2022
> Supply & Demand Value Chain
> Market - Current Trends
> Competition & Major Companies
> Technology and R&D Status
> Porters Five Force Analysis
> Strategic and Critical Success Factor Analysis of Key Players
Regional Analysis:
> North America
>> US and Canada
> Latin America
>> Mexico, Brazil, Argentina and Rest of Latin America
> Western Europe
>> EU5 (Germany, France, Italy, Spain, U.K.)
>> Nordic Countries (Denmark, Finland, Norway, and Sweden)
>> Benelux (Belgium, The Netherlands, and Luxembourg)
>> Rest of Western Europe
> Eastern Europe
>> Russia
>> Poland
>> Rest of Eastern Europe
> Asia Pacific
>> China
>> India
>> Japan
>> Australia and New Zealand
>> Rest of Asia Pacific
> Middle East and Africa
>> GCC countries (Saudi Arabia, Oman, Qatar, Bahrain, UAE and Kuwait)
>> South Africa
>> North Africa
>> Rest of Middle East and Africa
This report is an elaborate aggregation of primary inputs from industry experts and participants across the supply chain. It provides details on market segmentation which is derived from several product mapping exercises, macroeconomic parameters and other qualitative and quantitative insights. The impact of all such factors is delivered across multiple market segments and geographies.
Report Highlights:
> Detailed Historical Overview (Market Origins, Product Launch Timeline, etc.)
> Consumer and Pricing Analysis
> Market dynamics of the industry
> Market Segmentation
> Estimated Market Sizing in terms of volume and value
> Recent trends in Market and impact
> Research Status and Technology Overview
> Extensive Industry Structure Coverage
The United States pneumococcal & meningococcal vaccines market is set to surpass US$ 7.5 Million by the year end of 2025. “United States Pneumococcal & Meningococcal Vaccines Market by Company Profile, Deals Type, Brand Analysis, Share, Key Trends & Opportunities to 2025” presents an in–depth assessment of the United States pneumococcal & meningococcal vaccines market dynamics, opportunitie...
The global human immunodeficiency virus (HIV) drugs market size is expected to surpass US$ 30 billion by 2025. “Global Human Immunodeficiency Virus (HIV) Drugs Market 2019 – 2025: Top 22 Drugs Analysis, Key Trends, Players and Forecasts” presents an in-depth assessment of the global human immunodeficiency virus (HIV) drugs market dynamics, opportunities, future roadmap, competitive landscap...
The global 50 blockbuster drugs market size is estimated to reach a value of US$ 292 billion by 2025. ‘’Global Blockbuster Drugs Market 2015 - 2025: Top 50 Drugs Analysis, Deal Trends, Players and Forecasts” presents an in-depth assessment of the global blockbuster drugs market dynamics, opportunities, future roadmap, competitive landscape and discusses major trends. The report offers the m...